Greater Efficacy And Potency Of Obinutuzumab Compared With Rituximab In Chronic Lymphocytic Leukemia Patients Confirmed By A Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Model
BLOOD(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BLOOD(2017)